Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
P
318010
vs
K
KOSPI 200
Over the past 12 months, Pharmsville Co Ltd has underperformed KOSPI 200, delivering a return of -11% compared to KOSPI 200's +116% growth.
Stocks Performance
318010 vs KOSPI 200
Performance Gap
318010 vs KOSPI 200
Performance By Year
318010 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Pharmsville Co Ltd
Glance View
Pharmsville Co Ltd is a South Korean ingredient maker that develops and sells biotech-based raw materials for pharmaceuticals, health foods, and cosmetics. Its products are the kinds of building blocks other companies use to make medicines, supplements, and personal care products, rather than finished brands sold directly to consumers. The company makes money by selling these ingredients and related materials to drug makers, food manufacturers, cosmetic companies, and other industrial customers. In this business, Pharmsville sits upstream in the supply chain: it focuses on creating and producing specialized compounds, while its customers turn those inputs into final products under their own labels. What makes the business model distinctive is that it depends on technical know-how in fermentation, processing, and ingredient development, not on mass consumer marketing. That gives Pharmsville a role as a specialty supplier, where product quality, consistency, and regulatory fit matter more than branding at the retail level.